These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2832766)

  • 1. Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma.
    Rowland KM; Bonomi P; Taylor SG; Maffey S; Reddy S; Lee MS
    NCI Monogr; 1988; (6):323-5. PubMed ID: 2832766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
    Bonomi P; Rowland KM; Taylor SG; Pincus M; Reddy S; Lee MS; Faber LP; Warren W; Kittle CF
    NCI Monogr; 1988; (6):331-4. PubMed ID: 2832768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
    J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J; Auerbach M; Essig L; Fryer J; Fryer D
    J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
    Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Matsumoto H; Okazaki M; Katagami N
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
    Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
    Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer.
    Friess GG; Baikadi M; Harvey WH
    Cancer Treat Rep; 1987; 71(7-8):681-4. PubMed ID: 3038313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T; Fukuoka M; Negoro S; Sugiura T; Kawahara M; Kudoh S; Araki J; Nakagawa K; Yokozaki M; Yamakido M; Ariyoshi Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1091-6. PubMed ID: 10945001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Small-cell lung cancer: survival analysis over the last 10 years: 1980-1990].
    Berghmans T; Klastersky J
    Rev Med Brux; 1992 Oct; 13(8):279-81, 284-5. PubMed ID: 1332173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.